查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1769904

監管事務外包市場－全球產業分析、規模、佔有率、成長、趨勢和預測（2025-2035）

Regulatory Affairs Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 221 Pages | 商品交期: 2-10個工作天內

價格

監理事務外包市場-報告範圍

TMR 的全球監管事務外包市場報告研究了過去和當前的成長趨勢和機遇，旨在深入了解 2025 年至 2035 年預測期內的市場指標。該報告提供了 2019 年至 2035 年期間全球監管事務外包市場的收入，以 2025 年為基準年，2035 年為預測年。該報告還提供了 2025 年至 2035 年全球監管事務外包市場的年複合成長率(CAGR%)。

本報告經過廣泛的調查後編寫。主要研究工作包括分析師對關鍵意見領袖、產業領袖和輿論領袖的訪談。次要研究則參考了主要參與者的產品資料、年度報告、新聞稿和相關文件，以了解監管事務外包市場。

市場概況
2024 年的市場價值 74億美元
2035年的市場價值 223億美元
複合年成長率 10.6%

本報告深入探討了全球監管事務外包市場的競爭格局。報告確定了全球監管事務外包市場的主要參與者，並根據其各項屬性進行了分析。本報告對全球監管事務外包市場參與者的屬性進行了分析，包括公司概況、財務狀況、近期發展和 SWOT 分析。

目錄

第1章：前言

第2章：假設與研究方法

第3章：執行摘要：全球市場

第4章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020 年至 2035 年全球監理事務外包市場分析與預測

第5章：關鍵見解

  • 監理事務外包市場模式的當前趨勢概述
  • 波特五力分析
  • PESTEL分析
  • 重點地區/國家的監管狀況
  • 主要參與者/監管機構的服務發布/批准
  • 監理事務外包市場的併購情景
  • 對競爭對手提供的服務基準化分析
  • 監理事務外包服務的投資趨勢
  • 新市場進入者的市場進入策略

第6章：全球市場分析與預測：依服務類型

  • 介紹和定義
  • 主要發現/進展
  • 2020 年至 2035 年按服務類型分類的市場價值預測
    • 監管諮詢和法律代理
    • 產品註冊和臨床試驗申請
    • 法規撰寫與出版
    • 監管提交
    • 監管營運
    • 其他
  • 各服務類型的市場吸引力

第7章：全球市場分析與預測：依產品開發階段

  • 介紹和定義
  • 主要發現/進展
  • 2020 年至 2035 年按產品開發階段分類的市場價值預測
    • 臨床前
    • 臨床
    • PMA（上市後授權）
  • 各產品開發階段的市場吸引力

第8章：全球市場分析與預測：依企業規模

  • 介紹和定義
  • 主要發現/進展
  • 2020 年至 2035 年按企業規模分類的市場價值預測
    • 中小企業
    • 大型企業
  • 按企業規模分類的市場吸引力

第9章：全球市場分析與預測：依治療領域

  • 介紹和定義
  • 主要發現/進展
  • 2020 年至 2035 年按治療領域分類的市場價值預測
    • 腫瘤學
    • 神經病學
    • 心臟病學
    • 免疫學
    • 皮膚科
    • 其他
  • 各治療領域的市場吸引力

第10章：全球市場分析與預測：依最終用戶

  • 介紹和定義
  • 主要發現/進展
  • 2020 年至 2035 年終端用戶市場價值預測
    • 醫療器材公司
    • 生物製藥和製藥公司
    • 其他
  • 最終用戶的市場吸引力

第 11 章：全球市場分析與預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 各地區市場吸引力

第12章：北美市場分析與預測

  • 美國
  • 加拿大

第13章：歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 瑞士
  • 荷蘭
  • 歐洲其他地區

第14章：亞太市場分析與預測

  • 中國
  • 日本
  • 印度
  • 澳洲和紐西蘭
  • 韓國
  • 亞太其他地區

第15章：拉丁美洲市場分析與預測

  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區

第16章：中東和非洲市場分析與預測

  • 海灣合作理事會國家
  • 南非
  • 中東和非洲其他地區

第 17 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 各公司市佔率分析（2024 年）
  • 公司簡介
    • Accell Clinical Research, LLC
    • Genpact
    • CRITERIUM, INC
    • Promedica International
    • WuXi AppTec
    • Medpace
    • Charles River Laboratories
    • ICON plc
    • Parexel International Corporation
    • Freyr
    • PHARMALEX GMBH
    • Labcorp Drug Development
    • Other Prominent Players
Product Code: TMRGL3528

Regulatory Affairs Outsourcing Market - Scope of Report

TMR's report on the global regulatory affairs outsourcing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global regulatory affairs outsourcing market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global regulatory affairs outsourcing market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the regulatory affairs outsourcing market.

Market Snapshot
Market Value in 2024US$ 7.4 Bn
Market Value in 2035US$ 22.3 Bn
CAGR10.6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global regulatory affairs outsourcing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global regulatory affairs outsourcing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global regulatory affairs outsourcing market.

The report delves into the competitive landscape of the global regulatory affairs outsourcing market. Key players operating in the global regulatory affairs outsourcing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global regulatory affairs outsourcing market profiled in this report.

Key Questions Answered in Global regulatory affairs outsourcing Market Report:

  • What is the sales/revenue generated by regulatory affairs outsourcing across all regions during the forecast period?
  • What are the opportunities in the global regulatory affairs outsourcing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Regulatory Affairs Outsourcing Market - Research Objectives and Research Approach

The comprehensive report on the global regulatory affairs outsourcing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global regulatory affairs outsourcing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global regulatory affairs outsourcing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Regulatory Affairs Outsourcing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Regulatory Affairs Outsourcing Market Analysis and Forecasts, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Overview on Current Trends
  • 5.2. PORTER's Five Forces Analysis
  • 5.3. PESTEL Analysis
  • 5.4. Regulatory Scenario across Key Regions/Country
  • 5.5. Service Launches/Approvals by the Major Players/Regulatory Authority
  • 5.6. Mergers and Acquisition Scenario for Regulatory Affairs Outsourcing Market
  • 5.7. Benchmarking of the Services Offered by the Competitors
  • 5.8. Investment Trends in Regulatory Affairs Outsourcing Services
  • 5.9. Go-to-Market Strategy for New Market Entrants

6. Global Regulatory Affairs Outsourcing Market Analysis and Forecasts, By Service Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Service Type, 2020 to 2035
    • 6.3.1. Regulatory Consulting and Legal Representation
    • 6.3.2. Product Registration and Clinical Trial Applications
    • 6.3.3. Regulatory Writing and Publishing
    • 6.3.4. Regulatory Submission
    • 6.3.5. Regulatory Operations
    • 6.3.6. Others
  • 6.4. Market Attractiveness By Service Type

7. Global Regulatory Affairs Outsourcing Market Analysis and Forecasts, By Product Development Stage

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Product Development Stage, 2020 to 2035
    • 7.3.1. Preclinical
    • 7.3.2. Clinical
    • 7.3.3. PMA (Post Market Authorization)
  • 7.4. Market Attractiveness By Product Development Stage

8. Global Regulatory Affairs Outsourcing Market Analysis and Forecasts, By Enterprise Size

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Enterprise Size, 2020 to 2035
    • 8.3.1. Small/Medium Enterprises
    • 8.3.2. Large Enterprises
  • 8.4. Market Attractiveness By Enterprise Size

9. Global Regulatory Affairs Outsourcing Market Analysis and Forecasts, By Therapeutic Area

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 9.3.1. Oncology
    • 9.3.2. Neurology
    • 9.3.3. Cardiology
    • 9.3.4. Immunology
    • 9.3.5. Dermatology
    • 9.3.6. Others
  • 9.4. Market Attractiveness By Therapeutic Area

10. Global Regulatory Affairs Outsourcing Market Analysis and Forecasts, By End-user

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast By End-user, 2020 to 2035
    • 10.3.1. Medical Device Companies
    • 10.3.2. Biopharma & Pharmaceutical Companies
    • 10.3.3. Others
  • 10.4. Market Attractiveness By End-user

11. Global Regulatory Affairs Outsourcing Market Analysis and Forecasts, By Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast By Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness By Region

12. North America Regulatory Affairs Outsourcing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Service Type, 2020 to 2035
    • 12.2.1. Regulatory Consulting and Legal Representation
    • 12.2.2. Product Registration and Clinical Trial Applications
    • 12.2.3. Regulatory Writing and Publishing
    • 12.2.4. Regulatory Submission
    • 12.2.5. Regulatory Operations
    • 12.2.6. Others
  • 12.3. Market Value Forecast By Product Development Stage, 2020 to 2035
    • 12.3.1. Preclinical
    • 12.3.2. Clinical
    • 12.3.3. PMA (Post Market Authorization)
  • 12.4. Market Value Forecast By Enterprise Size, 2020 to 2035
    • 12.4.1. Small/Medium Enterprises
    • 12.4.2. Large Enterprises
  • 12.5. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 12.5.1. Oncology
    • 12.5.2. Neurology
    • 12.5.3. Cardiology
    • 12.5.4. Immunology
    • 12.5.5. Dermatology
    • 12.5.6. Others
  • 12.6. Market Value Forecast By End-user, 2020 to 2035
    • 12.6.1. Medical Device Companies
    • 12.6.2. Biopharma & Pharmaceutical Companies
    • 12.6.3. Others
  • 12.7. Market Value Forecast By Country, 2020 to 2035
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Service Type
    • 12.8.2. By Product Development Stage
    • 12.8.3. By Enterprise Size
    • 12.8.4. By Therapeutic Area
    • 12.8.5. By End-user
    • 12.8.6. By Country

13. Europe Regulatory Affairs Outsourcing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Service Type, 2020 to 2035
    • 13.2.1. Regulatory Consulting and Legal Representation
    • 13.2.2. Product Registration and Clinical Trial Applications
    • 13.2.3. Regulatory Writing and Publishing
    • 13.2.4. Regulatory Submission
    • 13.2.5. Regulatory Operations
    • 13.2.6. Others
  • 13.3. Market Value Forecast By Product Development Stage, 2020 to 2035
    • 13.3.1. Preclinical
    • 13.3.2. Clinical
    • 13.3.3. PMA (Post Market Authorization)
  • 13.4. Market Value Forecast By Enterprise Size, 2020 to 2035
    • 13.4.1. Small/Medium Enterprises
    • 13.4.2. Large Enterprises
  • 13.5. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 13.5.1. Oncology
    • 13.5.2. Neurology
    • 13.5.3. Cardiology
    • 13.5.4. Immunology
    • 13.5.5. Dermatology
    • 13.5.6. Others
  • 13.6. Market Value Forecast By End-user, 2020 to 2035
    • 13.6.1. Medical Device Companies
    • 13.6.2. Biopharma & Pharmaceutical Companies
    • 13.6.3. Others
  • 13.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 13.7.1. Germany
    • 13.7.2. UK
    • 13.7.3. France
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. Switzerland
    • 13.7.7. The Netherlands
    • 13.7.8. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Service Type
    • 13.8.2. By Product Development Stage
    • 13.8.3. By Enterprise Size
    • 13.8.4. By Therapeutic Area
    • 13.8.5. By End-user
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Regulatory Affairs Outsourcing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Service Type, 2020 to 2035
    • 14.2.1. Regulatory Consulting and Legal Representation
    • 14.2.2. Product Registration and Clinical Trial Applications
    • 14.2.3. Regulatory Writing and Publishing
    • 14.2.4. Regulatory Submission
    • 14.2.5. Regulatory Operations
    • 14.2.6. Others
  • 14.3. Market Value Forecast By Product Development Stage, 2020 to 2035
    • 14.3.1. Preclinical
    • 14.3.2. Clinical
    • 14.3.3. PMA (Post Market Authorization)
  • 14.4. Market Value Forecast By Enterprise Size, 2020 to 2035
    • 14.4.1. Small/Medium Enterprises
    • 14.4.2. Large Enterprises
  • 14.5. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 14.5.1. Oncology
    • 14.5.2. Neurology
    • 14.5.3. Cardiology
    • 14.5.4. Immunology
    • 14.5.5. Dermatology
    • 14.5.6. Others
  • 14.6. Market Value Forecast By End-user, 2020 to 2035
    • 14.6.1. Medical Device Companies
    • 14.6.2. Biopharma & Pharmaceutical Companies
    • 14.6.3. Others
  • 14.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. South Korea
    • 14.7.6. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Service Type
    • 14.8.2. By Product Development Stage
    • 14.8.3. By Enterprise Size
    • 14.8.4. By Therapeutic Area
    • 14.8.5. By End-user
    • 14.8.6. By Country/Sub-region

15. Latin America Regulatory Affairs Outsourcing Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Service Type, 2020 to 2035
    • 15.2.1. Regulatory Consulting and Legal Representation
    • 15.2.2. Product Registration and Clinical Trial Applications
    • 15.2.3. Regulatory Writing and Publishing
    • 15.2.4. Regulatory Submission
    • 15.2.5. Regulatory Operations
    • 15.2.6. Others
  • 15.3. Market Value Forecast By Product Development Stage, 2020 to 2035
    • 15.3.1. Preclinical
    • 15.3.2. Clinical
    • 15.3.3. PMA (Post Market Authorization)
  • 15.4. Market Value Forecast By Enterprise Size, 2020 to 2035
    • 15.4.1. Small/Medium Enterprises
    • 15.4.2. Large Enterprises
  • 15.5. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 15.5.1. Oncology
    • 15.5.2. Neurology
    • 15.5.3. Cardiology
    • 15.5.4. Immunology
    • 15.5.5. Dermatology
    • 15.5.6. Others
  • 15.6. Market Value Forecast By End-user, 2020 to 2035
    • 15.6.1. Medical Device Companies
    • 15.6.2. Biopharma & Pharmaceutical Companies
    • 15.6.3. Others
  • 15.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Argentina
    • 15.7.4. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Service Type
    • 15.8.2. By Product Development Stage
    • 15.8.3. By Enterprise Size
    • 15.8.4. By Therapeutic Area
    • 15.8.5. By End-user
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Regulatory Affairs Outsourcing Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast By Service Type, 2020 to 2035
    • 16.2.1. Regulatory Consulting and Legal Representation
    • 16.2.2. Product Registration and Clinical Trial Applications
    • 16.2.3. Regulatory Writing and Publishing
    • 16.2.4. Regulatory Submission
    • 16.2.5. Regulatory Operations
    • 16.2.6. Others
  • 16.3. Market Value Forecast By Product Development Stage, 2020 to 2035
    • 16.3.1. Preclinical
    • 16.3.2. Clinical
    • 16.3.3. PMA (Post Market Authorization)
  • 16.4. Market Value Forecast By Enterprise Size, 2020 to 2035
    • 16.4.1. Small/Medium Enterprises
    • 16.4.2. Large Enterprises
  • 16.5. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 16.5.1. Oncology
    • 16.5.2. Neurology
    • 16.5.3. Cardiology
    • 16.5.4. Immunology
    • 16.5.5. Dermatology
    • 16.5.6. Others
  • 16.6. Market Value Forecast By End-user, 2020 to 2035
    • 16.6.1. Medical Device Companies
    • 16.6.2. Biopharma & Pharmaceutical Companies
    • 16.6.3. Others
  • 16.7. Market Value Forecast By Country/Sub-region, 2020 to 2035
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Service Type
    • 16.8.2. By Product Development Stage
    • 16.8.3. By Enterprise Size
    • 16.8.4. By Therapeutic Area
    • 16.8.5. By End-user
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 17.2. Market Share Analysis By Company (2024)
  • 17.3. Company Profiles
    • 17.3.1. Accell Clinical Research, LLC
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Financial Overview
      • 17.3.1.3. Financial Overview
      • 17.3.1.4. Business Strategies
      • 17.3.1.5. Recent Developments
    • 17.3.2. Genpact
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Financial Overview
      • 17.3.2.3. Financial Overview
      • 17.3.2.4. Business Strategies
      • 17.3.2.5. Recent Developments
    • 17.3.3. CRITERIUM, INC
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Financial Overview
      • 17.3.3.3. Financial Overview
      • 17.3.3.4. Business Strategies
      • 17.3.3.5. Recent Developments
    • 17.3.4. Promedica International
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Financial Overview
      • 17.3.4.3. Financial Overview
      • 17.3.4.4. Business Strategies
      • 17.3.4.5. Recent Developments
    • 17.3.5. WuXi AppTec
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Financial Overview
      • 17.3.5.3. Financial Overview
      • 17.3.5.4. Business Strategies
      • 17.3.5.5. Recent Developments
    • 17.3.6. Medpace
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Financial Overview
      • 17.3.6.3. Financial Overview
      • 17.3.6.4. Business Strategies
      • 17.3.6.5. Recent Developments
    • 17.3.7. Charles River Laboratories
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Financial Overview
      • 17.3.7.3. Financial Overview
      • 17.3.7.4. Business Strategies
      • 17.3.7.5. Recent Developments
    • 17.3.8. ICON plc
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Financial Overview
      • 17.3.8.3. Financial Overview
      • 17.3.8.4. Business Strategies
      • 17.3.8.5. Recent Developments
    • 17.3.9. Parexel International Corporation
      • 17.3.9.1. Company Overview
      • 17.3.9.2. Financial Overview
      • 17.3.9.3. Financial Overview
      • 17.3.9.4. Business Strategies
      • 17.3.9.5. Recent Developments
    • 17.3.10. Freyr
      • 17.3.10.1. Company Overview
      • 17.3.10.2. Financial Overview
      • 17.3.10.3. Financial Overview
      • 17.3.10.4. Business Strategies
      • 17.3.10.5. Recent Developments
    • 17.3.11. PHARMALEX GMBH
      • 17.3.11.1. Company Overview
      • 17.3.11.2. Financial Overview
      • 17.3.11.3. Financial Overview
      • 17.3.11.4. Business Strategies
      • 17.3.11.5. Recent Developments
    • 17.3.12. Labcorp Drug Development
      • 17.3.12.1. Company Overview
      • 17.3.12.2. Financial Overview
      • 17.3.12.3. Financial Overview
      • 17.3.12.4. Business Strategies
      • 17.3.12.5. Recent Developments
    • 17.3.13. Other Prominent Players
      • 17.3.13.1. Company Overview
      • 17.3.13.2. Financial Overview
      • 17.3.13.3. Financial Overview
      • 17.3.13.4. Business Strategies
      • 17.3.13.5. Recent Developments

List of Tables

  • Table 01: Global Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Service Type, 2020 to 2035
  • Table 02: Global Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Product Development Stage, 2020 to 2035
  • Table 03: Global Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Enterprise Size, 2020 to 2035
  • Table 04: Global Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 05: Global Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 06: Global Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
  • Table 07: North America Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, by Country, 2020 to 2035
  • Table 08: North America Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, by Service Type, 2020 to 2035
  • Table 09: North America Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Product Development Stage, 2020 to 2035
  • Table 10: North America Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Enterprise Size, 2020 to 2035
  • Table 11: North America Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 12: North America Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 13: Europe Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 14: Europe Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, by Service Type, 2020 to 2035
  • Table 15: Europe Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Product Development Stage, 2020 to 2035
  • Table 16: Europe Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Enterprise Size, 2020 to 2035
  • Table 17: Europe Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 18: Europe Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 19: Asia Pacific Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 20: Asia Pacific Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, by Service Type, 2020 to 2035
  • Table 21: Asia Pacific Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Product Development Stage, 2020 to 2035
  • Table 22: Asia Pacific Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Enterprise Size, 2020 to 2035
  • Table 23: Asia Pacific Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 24: Asia Pacific Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 25: Latin America Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 26: Latin America Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, by Service Type, 2020 to 2035
  • Table 27: Latin America Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Product Development Stage, 2020 to 2035
  • Table 28: Latin America Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Enterprise Size, 2020 to 2035
  • Table 29: Latin America Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 30: Latin America Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 31: Middle East & Africa Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 32: Middle East & Africa Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, by Service Type, 2020 to 2035
  • Table 33: Middle East & Africa Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Product Development Stage, 2020 to 2035
  • Table 34: Middle East & Africa Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Enterprise Size, 2020 to 2035
  • Table 35: Middle East & Africa Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 36: Middle East & Africa Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

List of Figures

  • Figure 01: Global Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 02: Global Regulatory Affairs Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 03: Global Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 04: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Regulatory Consulting and Legal Representation, 2020 to 2035
  • Figure 05: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Product Registration and Clinical Trial Product Development Stages, 2020 to 2035
  • Figure 06: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Regulatory Writing and Publishing, 2020 to 2035
  • Figure 07: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Regulatory Submission, 2020 to 2035
  • Figure 08: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Regulatory Operations, 2020 to 2035
  • Figure 09: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 10: Global Regulatory Affairs Outsourcing Market Value Share Analysis, By Product Development Stage, 2024 and 2035
  • Figure 11: Global Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Product Development Stage, 2025 to 2035
  • Figure 12: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Preclinical, 2020 to 2035
  • Figure 13: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Clinical, 2020 to 2035
  • Figure 14: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by PMA (Post Market Authorization), 2020 to 2035
  • Figure 15: Global Regulatory Affairs Outsourcing Market Value Share Analysis, By Enterprise Size, 2024 and 2035
  • Figure 16: Global Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Enterprise Size, 2025 to 2035
  • Figure 17: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Small/Medium Enterprises, 2020 to 2035
  • Figure 18: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Large Enterprises, 2020 to 2035
  • Figure 19: Global Regulatory Affairs Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 20: Global Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 21: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Oncology, 2020 to 2035
  • Figure 22: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Neurology, 2020 to 2035
  • Figure 23: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Cardiology, 2020 to 2035
  • Figure 24: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Immunology, 2020 to 2035
  • Figure 25: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Dermatology, 2020 to 2035
  • Figure 26: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 27: Global Regulatory Affairs Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 28: Global Regulatory Affairs Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 29: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Medical Device Companies, 2020 to 2035
  • Figure 30: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Biopharma & Pharmaceutical Companies, 2020 to 2035
  • Figure 31: Global Regulatory Affairs Outsourcing Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 32: Global Regulatory Affairs Outsourcing Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 33: Global Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 34: North America Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 35: North America Regulatory Affairs Outsourcing Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 36: North America Regulatory Affairs Outsourcing Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 37: North America Regulatory Affairs Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 38: North America Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 39: North America Regulatory Affairs Outsourcing Market Value Share Analysis, By Product Development Stage, 2024 and 2035
  • Figure 40: North America Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Product Development Stage, 2025 to 2035
  • Figure 41: North America Regulatory Affairs Outsourcing Market Value Share Analysis, By Enterprise Size, 2024 and 2035
  • Figure 42: North America Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Enterprise Size, 2025 to 2035
  • Figure 43: North America Regulatory Affairs Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 44: North America Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 45: North America Regulatory Affairs Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 46: North America Regulatory Affairs Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 47: Europe Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 48: Europe Regulatory Affairs Outsourcing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 49: Europe Regulatory Affairs Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 50: Europe Regulatory Affairs Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 51: Europe Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 52: Europe Regulatory Affairs Outsourcing Market Value Share Analysis, By Product Development Stage, 2024 and 2035
  • Figure 53: Europe Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Product Development Stage, 2025 to 2035
  • Figure 54: Europe Regulatory Affairs Outsourcing Market Value Share Analysis, By Enterprise Size, 2024 and 2035
  • Figure 55: Europe Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Enterprise Size, 2025 to 2035
  • Figure 56: Europe Regulatory Affairs Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 57: Europe Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 58: Europe Regulatory Affairs Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 59: Europe Regulatory Affairs Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 60: Asia Pacific Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 61: Asia Pacific Regulatory Affairs Outsourcing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 62: Asia Pacific Regulatory Affairs Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 63: Asia Pacific Regulatory Affairs Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 64: Asia Pacific Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 65: Asia Pacific Regulatory Affairs Outsourcing Market Value Share Analysis, By Product Development Stage, 2024 and 2035
  • Figure 66: Asia Pacific Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Product Development Stage, 2025 to 2035
  • Figure 67: Asia Pacific Regulatory Affairs Outsourcing Market Value Share Analysis, By Enterprise Size, 2024 and 2035
  • Figure 68: Asia Pacific Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Enterprise Size, 2025 to 2035
  • Figure 69: Asia Pacific Regulatory Affairs Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 70: Asia Pacific Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 71: Asia Pacific Regulatory Affairs Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 72: Asia Pacific Regulatory Affairs Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 73: Latin America Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 74: Latin America Regulatory Affairs Outsourcing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 75: Latin America Regulatory Affairs Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 76: Latin America Regulatory Affairs Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 77: Latin America Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 78: Latin America Regulatory Affairs Outsourcing Market Value Share Analysis, By Product Development Stage, 2024 and 2035
  • Figure 79: Latin America Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Product Development Stage, 2025 to 2035
  • Figure 80: Latin America Regulatory Affairs Outsourcing Market Value Share Analysis, By Enterprise Size, 2024 and 2035
  • Figure 81: Latin America Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Enterprise Size, 2025 to 2035
  • Figure 82: Latin America Regulatory Affairs Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 83: Latin America Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 84: Latin America Regulatory Affairs Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 85: Latin America Regulatory Affairs Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 86: Middle East & Africa Regulatory Affairs Outsourcing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 87: Middle East & Africa Regulatory Affairs Outsourcing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 88: Middle East & Africa Regulatory Affairs Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 89: Middle East & Africa Regulatory Affairs Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 90: Middle East & Africa Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 91: Middle East & Africa Regulatory Affairs Outsourcing Market Value Share Analysis, By Product Development Stage, 2024 and 2035
  • Figure 92: Middle East & Africa Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Product Development Stage, 2025 to 2035
  • Figure 93: Middle East & Africa Regulatory Affairs Outsourcing Market Value Share Analysis, By Enterprise Size, 2024 and 2035
  • Figure 94: Middle East & Africa Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Enterprise Size, 2025 to 2035
  • Figure 95: Middle East & Africa Regulatory Affairs Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 96: Middle East & Africa Regulatory Affairs Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 97: Middle East & Africa Regulatory Affairs Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 98: Middle East & Africa Regulatory Affairs Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035